Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NPY1R | P25929 | 1/20 | 0.30 |
| ▸ | NPY2R | P49146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24456244 | 0.69 | NOS1 (0.48) | — | |
| SCHEMBL11355669 | 0.66 | EPHX1 (0.44) | RAB9ASMN1; SMN2NPY1RNPY2R | |
| SCHEMBL13655894 | 0.60 | HTR2A (0.33) | CYP1A2 | |
| SCHEMBL7922001 | 0.60 | TDP1 (0.47) | CYP3A4 | |
| Formic Acid SCHEMBL27372403 | 0.59 | CES2 (0.43) | CYP2C19 | |
| SCHEMBL30192806 | 0.58 | PSEN1 (0.48) | CYP1A2CYP3A4 | |
| SCHEMBL24875683 | 0.58 | PSEN1 (0.48) | CYP1A2CYP3A4 | |
| SCHEMBL3982818 | 0.57 | — | — | |
| SCHEMBL28172707 | 0.57 | HTR2A (0.41) | CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1853771 | 0.57 | TDP1 (0.45) | NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7767701-B2 | protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia | GLAXOSMITHKLINE LLC (US) | 2010-08-03 | — | — | US | disclosed |